Latest Topamax Stories

If you or anyone you know has taken Topamax during a pregnancy, the attorneys at d'Oliveira & Associates urge you to contact them immediately. (PRWEB) March 23, 2013 Topamax is a popular anticonvulsant prescription drug manufactured by the Johnson & Johnson subsidiary Ortho-McNeil Pharmaceutical. Originally approved by The U.S. Food and Drug Administration (FDA) in 1996 to treat persons experiencing epileptic seizures, the drug has since been approved as an anti-migraine drug...

The Consumer Justice Foundation, a for-profit corporation whose team of professional consumer advocates provides continuous updates regarding free online information relating to the potential dangers of using certain prescription medications, has a Web site URL that is located at http://www.topamaxbirthinjury.com. The CJF hereby reports that a study published by researchers in Taiwan concluded that the use of acupuncture by people suffering from migraine headaches reduced the episodes of...

The Consumer Justice Foundation, a for-profit corporation that is staffed by a team of professional consumer advocates whose mission is to provide consumers with information regarding the potential dangers of certain prescription medications via free online informational resources, hereby alerts the public of an FDA announcement that its decision regarding whether or not to approve the topiramate-containing obesity medication Qnexa will not be made on April 17. Instead, the agency will...

The Consumer Justice Foundation, a for-profit corporation that is staffed by professional consumer advocates who provide free online informational resources regarding certain prescription medications at the URL of http://www.topamaxbirthinjury.com, hereby alerts the public that a panel of FDA advisers has voted to back the approval of Qnexa, an obesity drug that contains Topamax, despite a rejection of this medication by the FDA in 2010 based on concerns of Topamax-related birth defects....

MAPLE GROVE, Minn., March 12, 2012 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (http://www.upsher-smith.com) today presented Phase I pharmacokinetic data evaluating the profiles of 10 internally developed once-daily, extended-release formulations of the epilepsy medication topiramate. Of the formulations investigated, one extended-release (ER) formulation of topiramate emerged as being optimal for further development by meeting all pre-established single-dose and simulated...

The Consumer Justice Foundation, a for-profit corporation that is staffed by a team of professional consumer advocates whose mission is to alert the public of potential dangers associated with the use of prescription medications and whose URL can be found at http://www.topamaxbirthinjury.com, hereby alerts the public to the posting of third-quarter sales of Topamax by Johnson & Johnson, the manufacturer of this medication. (PRWEB) October 27, 2011 The Consumer Justice Foundation, a...

The Rottenstein Law Group, which is now evaluating potential claims of those who have suffered injury as a result of taking the anticonvulsant drug Topamax, is recommending that any patient prescribed Topamax to aid with weight loss discuss the severe side effects of the drug with one's doctor in light of the conclusion of a recent study that Topamax might be useful as a weight-loss drug. New York, NY (PRWEB) June 27, 2011 Topamax is the brand name for the drug topiramate, an...

Topiramate is a medication that's been used for the treatment of the seizures associated with epilepsy, and in recent years it has also been used to treat the symptoms of migraine headaches. The Consumer Justice Foundation hereby announces that it has provided new information regarding the potential effects of Topiramate on unborn children of mothers who have used Topiramate for migraine headaches and who were unaware of the potential Topiramate side effects. This information can be...

Topamax, an antiepileptic and migraine medication, was analyzed in a recent European study that was designed to provide information regarding potential Topamax side effects and the potential harm that other medications could inflict on expecting mothers. The Consumer Justice Foundation provides information and statistical analysis so that knowledge regarding the potential effects of Topamax in women can be brought to public attention through resources such as...

The U.S. Food and Drug Administration (FDA) links Topamax® to cleft lip and cleft palate. Houston, Texas (PRWEB) May 13, 2011 The U.S. Food and Drug Administration (FDA) notified healthcare professionals and patients of a link between Topamax® (topiramate) and birth defects on March 4, 2011. Moulton & Arney, a litigation firm, is sponsoring TopamaxCleftLipLawyer.com, an online resource that aims to provide useful information about the Topamax® birth defect risk. "The...